Suppr超能文献

探讨利益相关者在痴呆症患者药物管理中的角色。

Exploring stakeholder roles in medication management for people living with dementia.

机构信息

Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.

Western Australian Centre for Health and Ageing, School of Medicine, University of Western Australia, Perth, Australia.

出版信息

Res Social Adm Pharm. 2021 Apr;17(4):707-714. doi: 10.1016/j.sapharm.2020.06.006. Epub 2020 Jun 6.

Abstract

BACKGROUND

Therapeutic decision making, prescribing, administering and managing medications can be difficult for people with dementia.

OBJECTIVES

To explore stakeholder roles in medication management for people with dementia, including barriers and enablers to achieving those roles.

METHODS

Focus groups were held with stakeholders (consumers, general practitioners, nurses and pharmacists) from both rural and metropolitan communities in two Australian states. Focus groups were audio-recorded, transcribed and thematically analysed using an inductive approach.

RESULTS

Nine focus groups were held with 55 participants. Four major themes were identified: supporting the role of the person with dementia, carer roles and challenges, health professional roles, and process and structure barriers to medication management. Stakeholders discussed the importance of advance care planning, and the potential benefits of early implementation of dose administration aids to support patients in self-managing their medication. Carers were seen to have a vital role as patient advocates, but carer burden and changes in the patient-carer roles acted as barriers to this role. General practitioners were perceived as the main care coordinator for a person with dementia, with effective interprofessional collaboration and communication with allied health professionals and specialists further enabling optimisation of medication use. A lack of evidence, guidelines and practitioner training to guide prescribing and deprescribing decisions in people with dementia were mentioned as barriers to medication management.

CONCLUSION

Medication management is increasingly challenging for people with dementia and each stakeholder perceives that they have a different role and faces different barriers and enablers. Future research should focus on improving the evidence base to guide prescribing, facilitating stakeholder communication and ensuring early documentation of patient wishes for the future.

摘要

背景

治疗决策、开处方、给药和管理药物对痴呆症患者来说可能很困难。

目的

探索利益相关者在痴呆症患者药物管理中的作用,包括实现这些角色的障碍和促进因素。

方法

在澳大利亚两个州的农村和城市社区,与利益相关者(消费者、全科医生、护士和药剂师)进行了焦点小组讨论。使用归纳方法对焦点小组进行录音、转录和主题分析。

结果

共进行了 9 次焦点小组讨论,共有 55 名参与者。确定了四个主要主题:支持痴呆症患者的角色、照顾者角色和挑战、卫生专业人员的角色以及药物管理的过程和结构障碍。利益相关者讨论了预先护理计划的重要性,以及尽早实施剂量给药辅助工具支持患者自我管理药物的潜在好处。照顾者被视为患者的重要倡导者,但照顾者的负担和患者-照顾者角色的变化成为该角色的障碍。全科医生被视为痴呆症患者的主要护理协调者,与其他卫生专业人员和专家进行有效的跨专业合作和沟通,进一步促进药物使用的优化。缺乏针对痴呆症患者的药物管理的指导处方和减少处方决策的证据、指南和从业者培训被认为是药物管理的障碍。

结论

药物管理对痴呆症患者来说越来越具有挑战性,每个利益相关者都认为他们有不同的角色,面临不同的障碍和促进因素。未来的研究应重点改善指导处方的证据基础,促进利益相关者之间的沟通,并确保及早记录患者对未来的愿望。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验